Halitosis as a rare adverse effect of atomoxetine in a child with attention-deficit/hyperactivity disorder
Dusunen Adam:The Journal of Psychiatry and Neurological Sciences · 12.06.2026 · 159-161
DOI: 10.14744/dajpns.2026.00330 ↗Kurz gefasst
Leserbrief in der Zeitschrift Dusunen Adam:The Journal of Psychiatry and Neurological Sciences, erschienen am 12.06.2026. Verfasst von Mujdat Erarkadas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Golcuk Necati Celik State Hospital, Department of Child and Adolescent Psychiatry, Kocaeli, Turkiye. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Dear Editor, Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in childhood that often requires pharmacological treatment (1).Atomoxetine, a selective norepinephrine reuptake inhibitor, is widely used as a non-stimulant medication for ADHD, particularly in patients who cannot tolerate stimulants or have contraindications (1, 2).Although atomoxetine's safety profile is generally well established, rare and atypical adverse effects may go unrecognized, especially in pediatric populations (3).This report presents a case of halitosis as a rare adverse effect occurring during atomoxetine treatment in a child with ADHD, highlighting an uncommon but clinically relevant side effect that may affect treatment adherence and quality of life.A 6-year-old boy was referred to a child psychiatry clinic due to hyperactivity and poor school adjustment.His prenatal, perinatal, and postnatal histories were unremarkable, and his developmental milestones were age appropriate.He had no prior medical or psychiatric diagnoses.During the evaluation, he was constantly moving, had difficulty remaining seated, was easily distracted during structured activities, and demonstrated a tendency to interrupt others or act impulsively.Based on clinical interviews, teacher feedback, and parent and teacher ratings on the Turgay DSM-IV-Based Disruptive Behavior Disorders
Autor:innen und Institutionen
- Golcuk Necati Celik State Hospital, Department of Child and Adolescent Psychiatry, Kocaeli, Turkiye.
- Kocaeli University, Faculty of Medicine, Department of Child and Adolescent Psychiatry, Kocaeli, Turkiye.
Zitieren
APA
Erarkadas, M., & Erarkadas, K. O. (2026). Halitosis as a rare adverse effect of atomoxetine in a child with attention-deficit/hyperactivity disorder. Dusunen Adam:The Journal of Psychiatry and Neurological Sciences, 159-161. https://doi.org/10.14744/dajpns.2026.00330
Vancouver
Erarkadas M, Erarkadas KO. Halitosis as a rare adverse effect of atomoxetine in a child with attention-deficit/hyperactivity disorder. Dusunen Adam:The Journal of Psychiatry and Neurological Sciences. 2026:159-161. doi:10.14744/dajpns.2026.00330
BibTeX
@article{Erarkadas2026,
author = {Erarkadas, Mujdat and Erarkadas, Kubra Ozmeral},
title = {Halitosis as a rare adverse effect of atomoxetine in a child with attention-deficit/hyperactivity disorder},
journal = {Dusunen Adam:The Journal of Psychiatry and Neurological Sciences},
year = {2026},
pages = {159--161},
doi = {10.14744/dajpns.2026.00330}
}
EUVIMED